Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection.

Amjad F AlFaleh Abdullah AlkattanAbrar AlzaherNashwa RadwanNagla MahmoudAlaa AlageelDina AlhabibEman AlsalameenKhlood SagorAlhan HajiAmal AlfaifiKhaled AlabdulkareemMona H Ibrahim

Published in: Clinical drug investigation (2022)

The current study revealed that the median protective duration of ChAdOx1 and BNT162b2 COVID-19 primary vaccination regimens administered in Saudi Arabia in 2021 was 134 days and that heterologous primary vaccination (ChAdOx1→BNT162b2) exhibited a significantly higher protective duration than other vaccination regimens.

Keyphrases

coronavirus disease
sars cov
single cell